Chief Executive Officer and Managing Director of Ranbaxy Laboratories Malvinder Singh answers a question during a press conference in New Delhi on June 11, 2008
1 of 1
Chief Executive Officer and Managing Director of Ranbaxy Laboratories Malvinder Singh answers a question during a press conference in New Delhi on June 11, 2008. The United States Food and Drug Administration (US FDA) has accused India`s largest generics drug maker, Ranbaxy Laboratories, of forging and concealing documents relating to an investigation into the quality of the company`s drugs sold in the US market and has filed a motion in the district court of Maryland seeking documents from the Indian firm. (AFP Photo)